belantamab mafodotin · Medicine question

For which patients is belantamab mafodotin (Blenrep) indicated in combination with bortezomib and dexamethasone?

Name: For which patients is belantamab mafodotin (Blenrep) indicated in combination with bortezomib and dexamethasone?
Published: 2026-11-08T01:37:35.868Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Belantamab mafodotin (Blenrep), combined with bortezomib and dexamethasone, is indicated for adults with multiple myeloma who have received at least one prior therapy.

Sources for this answer

Blenrep 100mg & 70 mg powder for concentrate for solution for infusionGlaxoSmithKline UK · emc · SmPC §4.1 Therapeutic Indications · Version 2Document updated 8 January 2026

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about belantamab mafodotin